In the last 12 months, insiders at enVVeno Medical made open-market sales of $4,922 and bought no shares on the open market.
| # | Insider | Position | Direct | Indirect | Total | Share of Insiders | Last Filed |
|---|---|---|---|---|---|---|---|
| 1 | Robert Andrew Berman | Chief Executive Officer | 6,349 | 0 | 6,349 | 65.1% | 19 Dec, 2024 |
| 2 | Francis Duhay | Director | 2,351 | 0 | 2,351 | 24.1% | 14 Sep, 2026 |
| 3 | Matthew Jenusaitis | Director | 473 | 0 | 473 | 4.8% | 23 Dec, 2024 |
| 4 | Robert Gray | Director | 319 | 0 | 319 | 3.3% | 02 Jan, 2025 |
| 5 | Sanjay Shrivastava | Director | 265 | 0 | 265 | 2.7% | 26 Dec, 2024 |
Each row is that insider’s most recently reported position, from Form 4 filings over the last 60 months — which is why this total does not tie to the quarterly series above, where a quarter counts only the insiders who filed in it. Shares held through a fund or institutional portfolio are counted on the institutional ownership page instead.
| Date | Insider | Position | Transaction | Shares | Price | Value | Shares Held After | Ownership |
|---|---|---|---|---|---|---|---|---|
| 11 Sep, 2026 | Francis Duhay | Director | Disposed S | 11 | $11.21 | $123 | 2,351 | Direct |
| 11 Jun, 2026 | Francis Duhay | Director | Disposed S | 140 | $10.31 | $1.44K | 2,362 | Direct |
| 12 Mar, 2026 | Francis Duhay | Director | Disposed S | 140 | $11.52 | $1.61K | 2,502 | Direct |
| 16 Dec, 2025 | Hamed Alavi | Chief Technology Officer | Disposed J | 50,000 | $0.00 | $0 | 0 | Direct |
| 16 Dec, 2025 | Robert Andrew Berman | Chief Executive Officer | Disposed J | 200,000 | $0.00 | $0 | 0 | Direct |
| 16 Dec, 2025 | Marc H. Glickman | Svp Chief Medical Officer | Disposed J | 100,000 | $0.00 | $0 | 0 | Direct |
| 11 Dec, 2025 | Sanjay Shrivastava | Director | Acquired A | 135,883 | $0.00 | $0 | 3,882 | Direct |
| 11 Dec, 2025 | Matthew Jenusaitis | Director | Acquired A | 135,883 | $0.00 | $0 | 3,882 | Direct |
| 11 Dec, 2025 | Francis Duhay | Director | Acquired A | 135,883 | $0.00 | $0 | 3,882 | Direct |
| 11 Dec, 2025 | Robert Gray | Director | Acquired A | 135,883 | $0.00 | $0 | 3,882 | Direct |
| 11 Dec, 2025 | Francis Duhay | Director | Disposed S | 4,900 | $12.45 | $60.99K | 2,644 | Direct |
| 15 Sep, 2025 | Francis Duhay | Director | Disposed S | 4,900 | $29.05 | $142.35K | 2,784 | Direct |
| 19 May, 2025 | Jennifer Bright | Chief Financial Officer | Acquired A | 350,000 | $0.00 | $0 | 10,000 | Direct |
| 31 Dec, 2024 | Francis Duhay | Director | Acquired P | 81,433 | $107.46 | $8.75Mn | 2,924 | Direct |
| 31 Dec, 2024 | Robert Gray | Director | Acquired P | 3,500 | $102.91 | $360.17K | 319 | Direct |
| 24 Dec, 2024 | Sanjay Shrivastava | Director | Acquired P | 5,400 | $101.51 | $548.13K | 265 | Direct |
| 19 Dec, 2024 | Matthew Jenusaitis | Director | Acquired P | 9,620 | $88.55 | $851.89K | 473 | Direct |
| 18 Dec, 2024 | Marc H. Glickman | Svp Chief Medical Officer | Acquired A | 75,000 | $0.00 | $0 | 2,143 | Direct |
| 18 Dec, 2024 | Matthew Jenusaitis | Director | Acquired A | 19,752 | $0.00 | $0 | 564 | Direct |
| 18 Dec, 2024 | Robert Andrew Berman | Chief Executive Officer | Acquired A | 200,000 | $0.00 | $0 | 5,714 | Direct |